Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study (vol 38, pg 2990, 2021)

被引:0
|
作者
Ansari, Ejaz [1 ]
Pavicic-Astalos, Jasna [2 ]
Ayan, Filis [3 ]
King, Anthony J. [4 ]
Kinsella, Matthew [5 ]
Ng, Eugene [2 ]
Nita, Anca [6 ]
机构
[1] Univ Kent, Maidstone & Tunbridge Wells NHS Trust, Canterbury, Kent, England
[2] UPMC Whitfield, Inst Eye Surg, Waterford, Ireland
[3] Santen UK Ltd, St Albans, England
[4] Nottingham Univ Hosp NHS Trust, Nottingham, England
[5] Stoke Mandeville Hosp, Buckinghamshire Healthcare NHS Trust, Aylesbury, Bucks, England
[6] Royal Victoria Infirm, Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
关键词
D O I
10.1007/s12325-021-01988-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:831 / 831
页数:1
相关论文
共 50 条
  • [1] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
    Ansari, Ejaz
    Pavicic-Astalos, Jasna
    Ayan, Filis
    King, Anthony J.
    Kinsella, Matthew
    Ng, Eugene
    Nita, Anca
    ADVANCES IN THERAPY, 2021, 38 (06) : 2990 - 3002
  • [2] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
    Ejaz Ansari
    Jasna Pavicic-Astalos
    Filis Ayan
    Anthony J. King
    Matthew Kinsella
    Eugene Ng
    Anca Nita
    Advances in Therapy, 2021, 38 : 2990 - 3002
  • [3] Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
    Ejaz Ansari
    Jasna Pavicic-Astalos
    Filis Ayan
    Anthony J. King
    Matthew Kinsella
    Eugene Ng
    Anca Nita
    Advances in Therapy, 2022, 39 : 831 - 831
  • [4] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
    Francesco Oddone
    Lucia Tanga
    Péter Kóthy
    Gábor Holló
    Advances in Therapy, 2020, 37 : 1436 - 1451
  • [5] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
    Oddone, Francesco
    Tanga, Lucia
    Kothy, Peter
    Hollo, Gabor
    ADVANCES IN THERAPY, 2020, 37 (04) : 1436 - 1451
  • [6] Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
    Francesco Oddone
    Lucia Tanga
    Péter Kóthy
    Gábor Holló
    Advances in Therapy, 2020, 37 : 3643 - 3644
  • [7] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain
    Garcia-Medina, Jose J.
    Benitez-del-Castillo, Javier
    Rodriguez-Agirretxe, Inaki
    Lopez-Lopez, Fernando
    Moreno-Valladares, Antonio
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 38 (03) : 252 - 260
  • [8] Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study (vol 37, pg 1436, 2020)
    Oddone, Francesco
    Tanga, Lucia
    Kothy, Peter
    Hollo, Gabor
    ADVANCES IN THERAPY, 2020, 37 (08) : 3643 - 3644
  • [9] Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
    Francesco Oddone
    James Kirwan
    Fernando Lopez-Lopez
    Marina Zimina
    Claudia Fassari
    Gábor Holló
    Advances in Therapy, 2022, 39 : 3501 - 3521
  • [10] Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes
    E. Ansari
    S. Chappiti
    J. Pavicic-Astalos
    J. C. Pinto-Bonilla
    I. Riva
    M. Sacchi
    F. Saénz-Francés
    BMC Ophthalmology, 22